Bellerophon Pulse Technologies

How to interpret these research links

Connected source records

The exact organization name Bellerophon Pulse Technologies appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary HypertensionNCT03267108 · lead sponsor · 2020-12-14

TERMINATED

Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled NitricNCT03602781 · lead sponsor · 2018-08-01

WITHDRAWN

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHNCT02725372 · lead sponsor · 2016-04-01

TERMINATED

Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAHNCT02652429 · lead sponsor · 2016-03-01

UNKNOWN

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPDNCT01728220 · lead sponsor · 2012-12-01

COMPLETED

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)NCT01457781 · lead sponsor · 2012-04-01

COMPLETED

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.